Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jinwei Lei

Showing results (1-10 of 10) with videos related to

Pageof 1
Sort By:
Turkish Neurosurgery|June 2, 2026
Pre-Therapeutic Vascular Anatomical Evaluation in Penetrating Cerebrovascular Injuries: Insights from Two CasesJinwei Lei, Gongbin Wei
International Journal of Pharmaceutics|July 7, 2026
Biomimetic hydrogel design for programmable ECM and tissue regenerationKaige Gao, Yutian Guan, Jinwei Lei, et al.
American Journal of Translational Research|March 23, 2026
HORMAD1 inhibits senescence and promotes proliferation of triple negative breast cancer by facilitating ubiquitination-mediated degradation of p27Beige Zong, Jinwei Lei, Meng Lou, et al.
Frontiers in Molecular Biosciences|December 28, 2020
KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric CancerQiulin Wu, Guobing Yin, Jinwei Lei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2020
A look into the link between centrosome amplification and breast cancerYingzi Zhang, Jiao Tian, Chi Qu, et al.
Breast Cancer (Tokyo, Japan)|February 11, 2021
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cellsYingzi Zhang, Jiao Tian, Chi Qu, et al.
Frontiers in Endocrinology|August 12, 2021
Comprehensive Analysis of the Expression and Prognostic Value of SPINT1/2 in Breast CarcinomaQiulin Wu, Guobing Yin, Jing Luo, et al.
Journal of Oncology|May 2, 2022
Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer PatientsYingkun Xu, Yang Peng, Meiying Shen, et al.
Oncology Reports|May 26, 2021
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Oncology Reports|July 23, 2021
[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Pageof 1

Showing results (1-10 of 10) with videos related to

Sort By:
Pageof 1
Turkish Neurosurgery|June 2, 2026
Pre-Therapeutic Vascular Anatomical Evaluation in Penetrating Cerebrovascular Injuries: Insights from Two CasesJinwei Lei, Gongbin Wei
International Journal of Pharmaceutics|July 7, 2026
Biomimetic hydrogel design for programmable ECM and tissue regenerationKaige Gao, Yutian Guan, Jinwei Lei, et al.
American Journal of Translational Research|March 23, 2026
HORMAD1 inhibits senescence and promotes proliferation of triple negative breast cancer by facilitating ubiquitination-mediated degradation of p27Beige Zong, Jinwei Lei, Meng Lou, et al.
Frontiers in Molecular Biosciences|December 28, 2020
KLHL5 Is a Prognostic-Related Biomarker and Correlated With Immune Infiltrates in Gastric CancerQiulin Wu, Guobing Yin, Jinwei Lei, et al.
Biomedicine & Pharmacotherapy = Biomedecine & Pharmacotherapie|October 31, 2020
A look into the link between centrosome amplification and breast cancerYingzi Zhang, Jiao Tian, Chi Qu, et al.
Breast Cancer (Tokyo, Japan)|February 11, 2021
Overexpression of SERPINA3 promotes tumor invasion and migration, epithelial-mesenchymal-transition in triple-negative breast cancer cellsYingzi Zhang, Jiao Tian, Chi Qu, et al.
Frontiers in Endocrinology|August 12, 2021
Comprehensive Analysis of the Expression and Prognostic Value of SPINT1/2 in Breast CarcinomaQiulin Wu, Guobing Yin, Jing Luo, et al.
Journal of Oncology|May 2, 2022
Construction and Validation of Angiogenesis-Related Prognostic Risk Signature to Facilitate Survival Prediction and Biomarker Excavation of Breast Cancer PatientsYingkun Xu, Yang Peng, Meiying Shen, et al.
Oncology Reports|May 26, 2021
HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Oncology Reports|July 23, 2021
[Corrigendum] HORMAD1 promotes docetaxel resistance in triple negative breast cancer by enhancing DNA damage toleranceBeige Zong, Lu Sun, Yang Peng, et al.
Pageof 1